BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 38574629)

  • 1. PSMA2 promotes glioma proliferation and migration via EMT.
    Zhang Y; Xiang Z; Chen L; Deng X; Liu H; Peng X
    Pathol Res Pract; 2024 Apr; 256():155278. PubMed ID: 38574629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclin-dependent kinase subunit2 (CKS2) promotes malignant phenotypes and epithelial-mesenchymal transition-like process in glioma by activating TGFβ/SMAD signaling.
    Feng F; Zhao Z; Cai X; Heng X; Ma X
    Cancer Med; 2023 Mar; 12(5):5889-5907. PubMed ID: 36284444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cullin-7 (CUL7) is overexpressed in glioma cells and promotes tumorigenesis via NF-κB activation.
    Xu J; Zhang Z; Qian M; Wang S; Qiu W; Chen Z; Sun Z; Xiong Y; Wang C; Sun X; Zhao R; Xue H; Li G
    J Exp Clin Cancer Res; 2020 Apr; 39(1):59. PubMed ID: 32252802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microrchidia family CW‑type zinc finger 2 promotes the proliferation, invasion, migration and epithelial‑mesenchymal transition of glioma by regulating PTEN/PI3K/AKT signaling via binding to N‑myc downstream regulated gene 1 promoter.
    Zhang J; Yang Y; Dong Y; Liu C
    Int J Mol Med; 2022 Feb; 49(2):. PubMed ID: 34913078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 11 Long noncoding RNA UCA1 functions as miR-135a sponge to promote the epithelial to mesenchymal transition in glioma.
    Li ZG; Xiang WC; Shui SF; Han XW; Guo D; Yan L
    J Cell Biochem; 2020 Mar; 121(3):2447-2457. PubMed ID: 31680311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoxia induced ferritin light chain (FTL) promoted epithelia mesenchymal transition and chemoresistance of glioma.
    Liu J; Gao L; Zhan N; Xu P; Yang J; Yuan F; Xu Y; Cai Q; Geng R; Chen Q
    J Exp Clin Cancer Res; 2020 Jul; 39(1):137. PubMed ID: 32677981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EMP3 as a prognostic biomarker correlates with EMT in GBM.
    Li L; Xia S; Zhao Z; Deng L; Wang H; Yang D; Hu Y; Ji J; Huang D; Xin T
    BMC Cancer; 2024 Jan; 24(1):89. PubMed ID: 38229014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ITGA2 as a prognostic factor of glioma promotes GSCs invasion and EMT by activating STAT3 phosphorylation.
    Zhang J; Li R; Zhang H; Wang S; Zhao Y
    Carcinogenesis; 2024 Apr; 45(4):235-246. PubMed ID: 38142122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting the Notch1 oncogene by miR-139-5p inhibits glioma metastasis and epithelial-mesenchymal transition (EMT).
    Li J; Li Q; Lin L; Wang R; Chen L; Du W; Jiang C; Li R
    BMC Neurol; 2018 Aug; 18(1):133. PubMed ID: 30170559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long non-coding RNA linc00673 regulated non-small cell lung cancer proliferation, migration, invasion and epithelial mesenchymal transition by sponging miR-150-5p.
    Lu W; Zhang H; Niu Y; Wu Y; Sun W; Li H; Kong J; Ding K; Shen HM; Wu H; Xia D; Wu Y
    Mol Cancer; 2017 Jul; 16(1):118. PubMed ID: 28697764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nitidine Chloride Is a Potential Alternative Therapy for Glioma Through Inducing Endoplasmic Reticulum Stress and Alleviating Epithelial-Mesenchymal Transition.
    Chen Z; Zhang J; Xue H; Qian M; Guo X; Gao X; Xu J; Qi Y; Sun X; Li G
    Integr Cancer Ther; 2020; 19():1534735419900927. PubMed ID: 32129091
    [No Abstract]   [Full Text] [Related]  

  • 12. TAGLN2 is a candidate prognostic biomarker promoting tumorigenesis in human gliomas.
    Han MZ; Xu R; Xu YY; Zhang X; Ni SL; Huang B; Chen AJ; Wei YZ; Wang S; Li WJ; Zhang Q; Li G; Li XG; Wang J
    J Exp Clin Cancer Res; 2017 Nov; 36(1):155. PubMed ID: 29110682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation of GPR160 inhibits the progression of glioma through suppressing epithelial to mesenchymal transition (EMT) biomarkers.
    Abbas A; Jun P; Yuan JY; Sun L; Jiang J; Yuan S
    Basic Clin Pharmacol Toxicol; 2022 Oct; 131(4):241-250. PubMed ID: 35771163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA RP11-84E24.3 drives tumorigenesis and epithelial-to-mesenchymal transition of glioma cells by promoting TFAP2C-mediated activation of SNAI1.
    Chang L; Wang J; Zhou F; Wang D; Chen R; Zhang Y; Zhang J
    J Neurooncol; 2021 Jan; 151(2):157-171. PubMed ID: 33128099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High expression of RAB43 predicts poor prognosis and is associated with epithelial-mesenchymal transition in gliomas.
    Han MZ; Huang B; Chen AJ; Zhang X; Xu R; Wang J; Li XG
    Oncol Rep; 2017 Feb; 37(2):903-912. PubMed ID: 28075478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A central role for MeCP2 in the epigenetic repression of miR-200c during epithelial-to-mesenchymal transition of glioma.
    Bian E; Chen X; Xu Y; Ji X; Cheng M; Wang H; Fang Z; Zhao B
    J Exp Clin Cancer Res; 2019 Aug; 38(1):366. PubMed ID: 31429770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The PDK1/c‑Jun pathway activated by TGF‑β induces EMT and promotes proliferation and invasion in human glioblastoma.
    Luo D; Xu X; Li J; Chen C; Chen W; Wang F; Xie Y; Li F
    Int J Oncol; 2018 Nov; 53(5):2067-2080. PubMed ID: 30106127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. G-protein Coupled Receptor 34 Promotes Gliomagenesis by Inducing Proliferation and Malignant Phenotype via TGF-Beta/Smad Signaling Pathway.
    Cheng Y; Heng X; Feng F
    Technol Cancer Res Treat; 2022; 21():15330338221105733. PubMed ID: 35770303
    [No Abstract]   [Full Text] [Related]  

  • 19. NKCC1 promotes EMT-like process in GBM via RhoA and Rac1 signaling pathways.
    Ma H; Li T; Tao Z; Hai L; Tong L; Yi L; Abeysekera IR; Liu P; Xie Y; Li J; Yuan F; Zhang C; Yang Y; Ming H; Yu S; Yang X
    J Cell Physiol; 2019 Feb; 234(2):1630-1642. PubMed ID: 30159893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TEAD4 functions as a prognostic biomarker and triggers EMT via PI3K/AKT pathway in bladder cancer.
    Chi M; Liu J; Mei C; Shi Y; Liu N; Jiang X; Liu C; Xue N; Hong H; Xie J; Sun X; Yin B; Meng X; Wang B
    J Exp Clin Cancer Res; 2022 May; 41(1):175. PubMed ID: 35581606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.